Axon Enterprise/ US05464C1018 /
30.05.2024 21:59:53 | Изменение -2.07 | Объем сделки | Бид22:25:01 | Предложение22:25:01 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
281.75USD | -0.73% | 10,370 Оборот: 903,414.50 |
170.01Величина цены спроса: 1 | 310.00Величина цены предложения: 1 | 21.26 млрдUSD | - | 119.89 |
GlobeNewswire
22:51
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...
GlobeNewswire
22:50
BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
GlobeNewswire
22:47
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
GlobeNewswire
22:38
Culinary Tours partners with Tennis Channel to create French-inspired recipes for French Open
GlobeNewswire
22:30
American Lithium Announces Financial and Operating Highlights for Year and Quarter Ended February 29...
GlobeNewswire
22:30
Ispire Technology Inc. to Present at the KCSA Cannabis Virtual Investor Conference June 5th
GlobeNewswire
22:30
Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
22:30
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncolo...
GlobeNewswire
22:30
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
GlobeNewswire
22:25
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница